Defendant

Lemelson Medical, Education & Research Foundation, LP

1 case as defendant.

Company profile

Lemelson Medical, Education & Research Foundation, LP

The Lemelson Medical, Education & Research Foundation, LP was a private, non-practicing entity (NPE) that controlled and asserted the patent portfolio of the prolific inventor Jerome "Jerry" Lemelson (1923-1997). Lemelson was one of America's most famous independent inventors, with over 600 patents to his name. Following his death, the foundation continued his strategy of demanding licensing fees from companies across numerous industries. A separate philanthropic entity, The Lemelson Foundation, was also established by Jerome and Dorothy Lemelson in 1992 and continues to operate out of Portland, Oregon, with a stated mission to support invention and innovation.

As a non-practicing entity, the foundation did not manufacture products or offer services. Its sole operation was to license and enforce the vast patent portfolio generated by Jerome Lemelson. The patents covered a wide range of technologies, most notably machine vision and bar-code scanning, but also technologies allegedly used in VCRs, camcorders, fax machines, and industrial robots. Starting in the late 1980s and continuing after his death, the Lemelson partnership launched a massive licensing campaign, reportedly collecting over $1.5 billion in royalties from hundreds of companies, including major Japanese and European automotive and electronics manufacturers.

The foundation's patent litigation posture was that of a classic patent assertion entity. While the provided database shows only one case as a defendant and zero as a plaintiff, this reflects the specific nature of that lawsuit. The case, Symbol Technologies, Inc. v. Lemelson Medical, Education & Research Foundation, LP, was a declaratory judgment action. Symbol Technologies and other technology companies preemptively sued the Lemelson foundation in the District of Nevada, seeking to have the patents declared invalid, unenforceable, and not infringed. This legal strategy is common for operating companies facing widespread licensing demands from an NPE.

The Symbol Technologies case proved to be a landmark for companies targeted by the Lemelson partnership. After years of litigation, the U.S. District Court for the District of Nevada ruled in 2004 that the asserted patent claims were unenforceable due to "prosecution laches"—an unreasonable and unexplained delay in the patent prosecution process. The court found that Lemelson had strategically delayed the issuance of his patents, some for decades, until the technologies became widely adopted by others. The patents were also found to be invalid for lack of enablement. This ruling effectively ended the foundation's controversial and highly lucrative licensing campaign.

Symbol Technologies, Inc. v. Lemelson Medical, Education & Research Foundation, LP

Judgment
Docket:
2:99-cv-00397
Patents:5243655

Symbol Technologies sought a declaratory judgment that numerous Lemelson patents were invalid, unenforceable, and not infringed. The courts found the asserted Lemelson patents unenforceable due to prosecution laches, and the decision was affirmed by the Federal Circuit.